Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Stem cell plays have cooled their jets since the news of Geron and Advanced Cell Technology becoming the first ...

Losses at Advanced Cell Technology (ACT) of Marlborough deepened in its first quarter, as the cost of clinical trials for its macular degeneration treatments rose, the company said. Advanced Cell ...